lung neoplasms

Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples
Jack Grant, Anne Stanley, Kevin Balbi, Gareth Gerrard, Philip Bennett

Journal of Clinical Pathology Apr 2022, 75 (4) 241-249; DOI: 10.1136/jclinpath-2020-207338
Next generation sequencing for detection of EGFR alterations in NSCLC: is more better?
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Parveen Jain, Anurag Mehta

Journal of Clinical Pathology Mar 2022, 75 (3) 164-167; DOI: 10.1136/jclinpath-2020-207212
Optimised architecture-based grading system as an independent prognostic factor in resected lung adenocarcinoma
Jin huan Qiu, Gui ming Hu, Rui zhen Zhang, Menglong Hu, Zongkuo Li, Yan Zhang, Hui fang Wu, Wen jing Fu, Min Zhang, Yi kun Feng, Lihua Niu, Jing li Ren

Journal of Clinical Pathology Mar 2022, 75 (3) 176-184; DOI: 10.1136/jclinpath-2020-207104
Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP)
Clara Salas, Javier Martín-López, Antonio Martínez-Pozo, Teresa Hernández-Iglesias, David Carcedo, Lucia Ruiz de Alda, J Francisco García, Federico Rojo

Journal of Clinical Pathology Mar 2022, 75 (3) 193-200; DOI: 10.1136/jclinpath-2020-207280
Prevalence and breakdown of EGFR exon 20 driver mutations in routine NHS lung cancer diagnostic testing
David Allan Moore, Kevin Jon Balbi, Benjamin Poskitt, Philip Bennett

Journal of Clinical Pathology Mar 2022, 75 (3) 209-210; DOI: 10.1136/jclinpath-2021-207643
Double staining of elastic fibre and immunohistochemistry is helpful to differentiate pleural invasion of lung cancer
Guihua Shen, Jiyan Dong, Zheng Xiang, Li Liu, Lin Yang

Journal of Clinical Pathology Mar 2022, 75 (3) 215-216; DOI: 10.1136/jclinpath-2021-207779
Clinicopathological characteristic of ciliated muconodular papillary tumour of the lung
Yong Yang, Xiaofeng Xie, Gening Jiang, Liping Zhang, Hongcheng Liu

Journal of Clinical Pathology Feb 2022, 75 (2) 128-132; DOI: 10.1136/jclinpath-2020-207205
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: a retrospective study
Antonino Iaccarino, Pasquale Pisapia, Francesco Pepe, Roberta Sgariglia, Mariantonia Nacchio, Gianluca Russo, Gianluca Gragnano, Caterina De Luca, Giancarlo Troncone, Umberto Malapelle

Journal of Clinical Pathology Jan 2022, 75 (1) 58-60; DOI: 10.1136/jclinpath-2020-207107
Challenging of frozen diagnoses of small sclerosing pneumocytoma
Zhanxian Shang, Yuchen Han, Jinchen Shao, Lei Zhu, Haohua Teng, Jie Zhang

Journal of Clinical Pathology Nov 2021, 74 (11) 730-734; DOI: 10.1136/jclinpath-2020-206729
PD-L1 expression by Tumor Proportion Score (TPS) and Combined Positive Score (CPS) are similar in non-small cell lung cancer (NSCLC)
Pedro De Marchi, Leticia Ferro Leal, Vinicius Duval da Silva, Eduardo Caetano Albino da Silva, Vladmir Claudio Cordeiro de Lima, Rui Manuel Reis

Journal of Clinical Pathology Nov 2021, 74 (11) 735-740; DOI: 10.1136/jclinpath-2020-206832

Main menu

lung neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

lung neoplasms

Pages